Advertisement Pharmaceutical Business review - Page 13 of 5226 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
November 26, 2024

FDA accepts Alnylam’s vutrisiran sNDA to treat ATTR-CM

The US Food and Drug Administration (FDA) has accepted a supplemental new drug application (sNDA) of Alnylam Pharmaceuticals’ vutrisiran for review.

Continue
Vutrisiran is an RNAi therapeutic aimed at treating transthyretin amyloidosis with cardiomyopathy. Credit: jesse orrico on Unsplash.
November 25, 2024

FDA approves StemCyte’s cord blood stem cell therapy BLA

The ongoing Phase II clinical trials for the treatment of long COVID syndrome and acute stroke are being conducted by the company. Credit: National Cancer Institute on Unsplash.
November 22, 2024

Dyadic receives grant from Gates Foundation for RSV antibody development

The $3m grant is to develop monoclonal antibodies for treatment of respiratory syncytial virus and malaria. Credit: National Institute of Allergy and Infectious Diseases on Unsplash.

Contracts

August 9, 2024

Bavarian Nordic secures $156.8m US vaccine deal

The vaccine is marketed under various brand names. Credit: Mathurin NAPOLY / matnapo on Unsplash.

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Harbour BioMed, Moderna partner on immunotherapies development

Deals

Deals July 15, 2024

Merck enhances ophthalmology portfolio with EyeBio acquisition

Pharmaceutical Business Review

Biocon signs licensing and supply deal for diabetes drug in Brazil

Q32 Bio concludes merger deal with Homology Medicines

Zuellig Pharma acquires Cialis and Alimta brands from Lilly

Popular

  1. Laekna partners with Lilly to develop obesity therapy
  2. FDA grants ODD to Ractigen Therapeutics’ RAG-21 for ALS treatment
  3. Arrowhead Pharmaceuticals submits plozasiran NDA to treat FCS
  4. Numab Therapeutics and Kaken Pharmaceutical collaborate to develop ND081
  5. FDA to review Sanofi, Regeneron’s Dupixent sBLA for CSU

PRESS RELEASES

Tosoh Bioscience – Separation & Purification Expands European Headquarters in Griesheim, Germany
Tosoh Bioscience – Separation & Purification Expands European Headquarters in Griesheim, Germany
BioSeparation Sustainable Biochromatography Forum ‒ Join Us in Vienna on 27 November 2024
BioSeparation Sustainable Biochromatography Forum ‒ Join Us in Vienna on 27 November 2024
Gerresheimer Gx Elite Vials: Best Drug Protection and Production Efficiency
Gerresheimer Gx Elite Vials: Best Drug Protection and Production Efficiency
Gerresheimer: EcoVadis Gold with Further Improved Score
Gerresheimer: EcoVadis Gold with Further Improved Score
Gerresheimer: Innovative Silicone Oil-Free Syringe Systems for Sensitive Ophthalmic Drugs
Gerresheimer: Innovative Silicone Oil-Free Syringe Systems for Sensitive Ophthalmic Drugs

Suppliers

Whitepapers

Saving Through Partnership and Innovation
Saving Through Partnership and Innovation
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Wound Care – Selecting the Right Antiseptic for Your Formulation
Wound Care – Selecting the Right Antiseptic for Your Formulation